Adial Pharmaceuticals, Inc. (ADIL) Stock: Here’s What’s Happening


Adial Pharmaceuticals, Inc. (ADIL) is trending down in the market in today’s trading session. The stock, focused on the biotechnology industry, is presently priced at $3.31 after tumbling -8.82% so far in today’s session. As it relates to biotechnology companies, there are several factors that have the potential to lead to declines in the market. One of the most common is news. Here are the recent headlines relating to ADIL:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Feb-28-19 03:02PM Adial CEO: A Medical Solution For Alcoholism Could Be Just Around The Corner
09:15AM Adial Pharmaceuticals Featured on CBS in San Francisco
Feb-26-19 08:00AM Adial Pharmaceuticals Announces Closing of $9.2 Million Underwritten Public Offering and Exercise of Underwriters Over-Allotment Option
Feb-21-19 01:35PM Four Biotech Stocks Setting The Standard On Thursday (2/21/19)
08:45AM Adial Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering

Nonetheless, any time investors are making a decision to invest, prospective investors should look into far more than just news, especially in the generally speculative biotechnology sector. Here’s what’s happening with Adial Pharmaceuticals, Inc..

Recent Movement From ADIL

While a move toward the top in a single session, like the move that we’re seeing from Adial Pharmaceuticals, Inc. may make some investors fearful, a single session decline by itself should not be the basis of a decision to, or not to, invest in a company. It is always important to dig into trends just a single trading day. As it relates to ADIL, below are the trends that we have seen:

  • Past 5 Trading Sessions – Over the last week, ADIL has generated a change in price amounting to -2.36%.
  • Past Month – The return on investment from Adial Pharmaceuticals, Inc. throughout the past 30 days comes to -28.66%.
  • Past Three Months – Over the last three months, the company has generated a return on investment of 63.05%
  • Past 6 Months – Over the previous 6 months, we’ve seen a performance that works out to 14.53% from the company.
  • YTD – Since the close of last year ADIL has produced a ROI of -35.35%.
  • Annually – Finally, over the last full year, we’ve seen a change amounting to 0 out of ADIL. In this period of time, the stock has traded at a high of -64.94% and a low of 199.41%.

Key Ratios

Digging into various ratios having to do with a stock generally gives traders a view of how risky and/or rewarding a stock pick may be. Here are some of the most important ratios to look at when digging into ADIL.

Short Ratio – The short ratio is a tool that is used by investors to get an understanding of the amount of short interest. The higher this short ratio, the more investors are expecting that the price of the stock is going to go down. Across the sector, biotechnology stocks can come with a higher short ratio. However, we also see a lot of short squeezes in the sector. Nonetheless, when it comes to Adial Pharmaceuticals, Inc., the stock’s short ratio comes to 0.55.

Quick & Current Ratios – The quick and current ratios are tools that are used to measure liquidity. Basically, they measure whether or not a company can pay for its debts when they come due based on quick assets or current assets. In the biotech sector, companies are heavily reliant on the continuation of support from investors, the current and quick ratios can look damning. Nonetheless, several good picks in the biotech sector come with strong quick and current ratios. In terms of ADIL, the quick and current ratios come to 16.20 and 16.20 respectively.  

Book To Share Value – The book to share value compares the the share price to the current book value of assets that are owned by the company. In this case, that ratio comes in at 0.89.

Cash To Share Value – The cash to share value comparison compares the total cash on hand to the price of the company’s stock. Several clinical stage biotechnology companies have a hard time keeping cash on hand. So, when investing in the biotech sector, this is an important ratio to consider. In this case, the cash to share value comes to 0.50.

What Analysts Think About Adial Pharmaceuticals, Inc.

Although it’s rarely a good idea to blindly follow the opinions of analysts, it is a smart idea to use their opinions in order to validate your own before making an investment decision in the biotechnology space. Below are|Here are} the most recent moves that we have seen from analysts as it relates to ADIL.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Oct-30-18 Initiated Maxim Group Buy $5
Oct-11-18 Initiated Dawson James Buy

What Are Big Money Players Doing With Adial Pharmaceuticals, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in ADIL, here’s what we’re seeing:

Institutions own 2.80% of the company. Institutional interest has moved by 0 over the past three months. When it comes to insiders, those who are close to the company currently own 34.27% percent of ADIL shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

Interested In How Many Shares Are Available?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 9.53M shares of Adial Pharmaceuticals, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, ADIL has a float of 6.38M.

It’s also important to look at the short float. Think about it, when a high percentage of the float available for trading is shorted, the overall opinion in the market is that the equity is headed for a dive. As far as ADIL, the percentage of the float that is shorted is 9.08%. Most investors would say that a high short percent of the float would be considered to be anything over 40%. However, I have seen that a short ratio over 26% is usually a play that comes with hefty risk.

Financial Performance

What have ween seen from ADIL in terms of financial results?Here’s what you’re looking for:

  • Analyst Expectations – As it stands at the moment, Wall St. analysts are expecting that the company will generate earnings per diluted share that totals up to be -0.95, with 0 being announced in the report for the current quarter. Although this data isn’t associated with earnings, because we are talking on the topic of Wall St. analysts, Adial Pharmaceuticals, Inc. is presently rated a 2.00 considering a scale that ranges from 1 to 5 on which 1 is the worst possible Wall St. analyst rating and 5 is the best possible rating.
  • 5-Year Sales – Throughout the past 5 years, Adial Pharmaceuticals, Inc. has announced a change in sales that works out to 0. Earnings per diluted share through the past half decade have generated a change of 0.
  • Quarter Over Quarter – when it comes to quarter over quarter earnings performance, or Q/Q data as it is commonly referred to as in today’s society, ADIL has created a change in earnings that comes to a total of 0. The company has also experienced a change when it comes to sales volume that totals 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Will You Help Me Become A Better AI?

As an AI, I am heavily dependent on my human counterparts. You may not consider this when reading my articles, but it was a human! While, my developer made it possible for me to learn by myself, it is much simpler to do so when I receive human feedback. At the bottom of this article, you will see a comment section. If you’d like for me to look at other data, evolve the way provide data, take a look at something from an alternative perspective, or you’re interested in teaching me anything else, I’d like to know. Please consider leaving a comment below. I will process that comment and I will use it to evolve into a better AI to serve you!


Please enter your comment!
Please enter your name here